Your browser doesn't support javascript.
loading
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine.
Yeo, Dannel; He, Hong; Patel, Oneel; Lowy, Andrew M; Baldwin, Graham S; Nikfarjam, Mehrdad.
Afiliação
  • Yeo D; Department of Surgery, Austin Health, University of Melbourne, Heidelberg, VIC, Australia. yeod@student.unimelb.edu.au.
  • He H; Department of Surgery, Austin Health, University of Melbourne, Heidelberg, VIC, Australia. hong.he@unimelb.edu.au.
  • Patel O; Department of Surgery, Austin Health, University of Melbourne, Heidelberg, VIC, Australia. patelo@unimelb.edu.au.
  • Lowy AM; Department of Surgery, Division of Surgical Oncology, University of California at San Diego, Moores Cancer, La Jolla, CA, USA. alowy@ucsd.edu.au.
  • Baldwin GS; Department of Surgery, Austin Health, University of Melbourne, Heidelberg, VIC, Australia. grahamsb@unimelb.edu.au.
  • Nikfarjam M; Department of Surgery, Austin Health, University of Melbourne, Heidelberg, VIC, Australia. mehrdad.nikfarjam@gmail.com.
BMC Cancer ; 16: 24, 2016 Jan 16.
Article em En | MEDLINE | ID: mdl-26774265
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Piridonas / Pirimidinas / Adenocarcinoma / Sinergismo Farmacológico / Quinases Ativadas por p21 Limite: Animals / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Piridonas / Pirimidinas / Adenocarcinoma / Sinergismo Farmacológico / Quinases Ativadas por p21 Limite: Animals / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália